Prevention of invasive fungal infections during allogeneic bone marrow transplantation in patients with a high risk of this complication. Treatment of adults and children with: - invasive aspergillosis; - candidemia not accompanied by neutropenia; - severe invasive infections caused by Candida (including C. krusei), resistant to fluconazole; - severe fungal infections caused by Scedosporium and Fusarium species. As initial therapy in patients with progressive, potentially life-threatening infections.